查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1624349

細胞治療市場 - 2024-2034 年全球產業分析、規模、佔有率、成長、趨勢和預測

Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 161 Pages | 商品交期: 2-10個工作天內

價格

細胞治療市場 - 報告範圍

TMR 關於全球細胞治療市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。 ，考慮2024年為基準年，2034年為預測年。報告中也提供了2024年至2034年全球細胞治療市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解細胞治療市場。

市場概況
2023年市場價值 48 億美元
2034 年市場價值 446 億美元
複合年成長率 20.8%

該報告深入探討了全球細胞治療市場的競爭格局。全球細胞治療市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球細胞治療市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034 年全球市場分析與預測

第 5 章：關鍵見解

  • 波特五力分析
  • PEST分析
  • 重要行業事件 - 產品批准
  • 重要產業活動 - 夥伴關係與協作

第 6 章：全球市場分析與預測：按類型

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按類型分類的市場價值預測
    • T-
      • 嵌合抗原受體 (CAR) T 細胞
      • T細胞受體
      • 腫瘤浸潤淋巴細胞
    • 幹
    • 自然殺手細胞
    • 樹突狀細胞
    • 其他細胞療法
  • 按類型分類的市場吸引力

第 7 章：全球市場分析與預測：按產地分類

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按產地分類的市場價值預測
    • 自體療法
    • 同種異體療法
  • 按原產地分類的市場吸引力

第 8 章：全球市場分析與預測：按治療領域

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年治療領域市場價值預測
    • 腫瘤疾病
    • 自體免疫疾病
    • 神經系統疾病
    • 其他
  • 按治療領域分類的市場吸引力

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 10 章：北美市場分析與預測

  • 美國
  • 加拿大

第 11 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第 12 章：亞太市場分析與預測

  • 中國
  • 印度
  • 日本
  • 澳洲和紐西蘭
  • 亞太地區其他地區

第 13 章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區

第 14 章：中東和非洲市場分析與預測

  • 海灣合作理事會
  • 南非
  • 中東和非洲其他地區

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 公司市佔率分析 (2023)
  • 公司簡介
    • Novartis AG
    • Bristol-Myers Squibb Company
    • IOVANCE Biotherapeutics, Inc.
    • Janssen Biotech, Inc.
    • CellTrans, Inc.
    • Gamida Cell Inc.
    • Dendreon Pharmaceuticals LLC
    • Kite Pharma, Inc.
    • Adaptimmune
    • Takeda Pharmaceutical Company Limited
Product Code: TMRGL63273

Cell Therapy Market - Scope of Report

TMR's report on the global cell therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global cell therapy market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cell therapy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cell therapy market.

Market Snapshot
Market Value in 2023US$ 4.8 Bn
Market Value in 2034US$ 44.6 Bn
CAGR20.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cell therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cell therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cell therapy market.

The report delves into the competitive landscape of the global cell therapy market. Key players operating in the global cell therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cell therapy market profiled in this report.

Key Questions Answered in Global cell therapy Market Report:

  • What is the sales/revenue generated by cell therapy across all regions during the forecast period?
  • What are the opportunities in the global cell therapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Cell Therapy Market - Research Objectives and Research Approach

The comprehensive report on the global cell therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cell therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cell therapy market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Cell Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cell Therapy Market Analysis and Forecasts, 2020-2034

5. Key Insights

  • 5.1. Porter's Five Forces Analysis
  • 5.2. PEST Analysis
  • 5.3. Key Industry Events - Product Approvals
  • 5.4. Key Industry Events - Partnerships and Collaborations

6. Global Cell Therapy Market Analysis and Forecasts, By Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type, 2020-2034
    • 6.3.1. T-cell Therapy
      • 6.3.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 6.3.1.2. T-cell Receptors
      • 6.3.1.3. Tumor-Infiltrating Lymphocytes
    • 6.3.2. Stem Cell Therapy
    • 6.3.3. Natural Killer Cells
    • 6.3.4. Dendritic Cells
    • 6.3.5. Other Cell Therapies
  • 6.4. Market Attractiveness By Type

7. Global Cell Therapy Market Analysis and Forecasts, By Origin

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Origin, 2020-2034
    • 7.3.1. Autologous Therapies
    • 7.3.2. Allogenic Therapies
  • 7.4. Market Attractiveness By Origin

8. Global Cell Therapy Market Analysis and Forecasts, By Therapeutic Area

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Therapeutic Area, 2020-2034
    • 8.3.1. Oncological Disorders
    • 8.3.2. Autoimmune Disorders
    • 8.3.3. Neurological Disorders
    • 8.3.4. Others
  • 8.4. Market Attractiveness By Therapeutic Area

9. Global Cell Therapy Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Cell Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Type, 2020-2034
    • 10.2.1. T-cell Therapy
      • 10.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 10.2.1.2. T-cell Receptors
      • 10.2.1.3. Tumor-Infiltrating Lymphocytes
    • 10.2.2. Stem Cell Therapy
    • 10.2.3. Natural Killer Cells
    • 10.2.4. Dendritic Cells
    • 10.2.5. Other Cell Therapies
  • 10.3. Market Value Forecast By Origin, 2020-2034
    • 10.3.1. Autologous Therapies
    • 10.3.2. Allogenic Therapies
  • 10.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 10.4.1. Oncological Disorders
    • 10.4.2. Autoimmune Disorders
    • 10.4.3. Neurological Disorders
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Origin
    • 10.6.3. By Therapeutic Area
    • 10.6.4. By Country

11. Europe Cell Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type, 2020-2034
    • 11.2.1. T-cell Therapy
      • 11.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 11.2.1.2. T-cell Receptors
      • 11.2.1.3. Tumor-Infiltrating Lymphocytes
    • 11.2.2. Stem Cell Therapy
    • 11.2.3. Natural Killer Cells
    • 11.2.4. Dendritic Cells
    • 11.2.5. Other Cell Therapies
  • 11.3. Market Value Forecast By Origin, 2020-2034
    • 11.3.1. Autologous Therapies
    • 11.3.2. Allogenic Therapies
  • 11.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 11.4.1. Oncological Disorders
    • 11.4.2. Autoimmune Disorders
    • 11.4.3. Neurological Disorders
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Origin
    • 11.6.3. By Therapeutic Area
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Cell Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type, 2020-2034
    • 12.2.1. T-cell Therapy
      • 12.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 12.2.1.2. T-cell Receptors
      • 12.2.1.3. Tumor-Infiltrating Lymphocytes
    • 12.2.2. Stem Cell Therapy
    • 12.2.3. Natural Killer Cells
    • 12.2.4. Dendritic Cells
    • 12.2.5. Other Cell Therapies
  • 12.3. Market Value Forecast By Origin, 2020-2034
    • 12.3.1. Autologous Therapies
    • 12.3.2. Allogenic Therapies
  • 12.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 12.4.1. Oncological Disorders
    • 12.4.2. Autoimmune Disorders
    • 12.4.3. Neurological Disorders
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Origin
    • 12.6.3. By Therapeutic Area
    • 12.6.4. By Country/Sub-region

13. Latin America Cell Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type, 2020-2034
    • 13.2.1. T-cell Therapy
      • 13.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 13.2.1.2. T-cell Receptors
      • 13.2.1.3. Tumor-Infiltrating Lymphocytes
    • 13.2.2. Stem Cell Therapy
    • 13.2.3. Natural Killer Cells
    • 13.2.4. Dendritic Cells
    • 13.2.5. Other Cell Therapies
  • 13.3. Market Value Forecast By Origin, 2020-2034
    • 13.3.1. Autologous Therapies
    • 13.3.2. Allogenic Therapies
  • 13.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 13.4.1. Oncological Disorders
    • 13.4.2. Autoimmune Disorders
    • 13.4.3. Neurological Disorders
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Origin
    • 13.6.3. By Therapeutic Area
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Cell Therapy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type, 2020-2034
    • 14.2.1. T-cell Therapy
      • 14.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 14.2.1.2. T-cell Receptors
      • 14.2.1.3. Tumor-Infiltrating Lymphocytes
    • 14.2.2. Stem Cell Therapy
    • 14.2.3. Natural Killer Cells
    • 14.2.4. Dendritic Cells
    • 14.2.5. Other Cell Therapies
  • 14.3. Market Value Forecast By Origin, 2020-2034
    • 14.3.1. Autologous Therapies
    • 14.3.2. Allogenic Therapies
  • 14.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 14.4.1. Oncological Disorders
    • 14.4.2. Autoimmune Disorders
    • 14.4.3. Neurological Disorders
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 14.5.1. GCC
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Origin
    • 14.6.3. By Therapeutic Area
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Novartis AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Bristol-Myers Squibb Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. IOVANCE Biotherapeutics, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Janssen Biotech, Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. CellTrans, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Gamida Cell Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Dendreon Pharmaceuticals LLC
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Kite Pharma, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Adaptimmune
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Takeda Pharmaceutical Company Limited
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments

Cell Therapy Market

Cell Therapy Industry

Cell Therapy Market Size

Cell Therapy Market Share

Cell Therapy Market Growth

Cell Therapy Market Analysis

Cell Therapy Market Demand

Cell Therapy Market Forecast

Cell Therapy Market Trends

List of Tables

  • Table 01: Global Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 02: Global Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 03: Global Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 04: Global Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 05: Global Cell Therapy Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 08: North America Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 09: North America Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 10: North America Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 11: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 13: Europe Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 14: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 15: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 16: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 18: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 19: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 20: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 21: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 23: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 24: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 25: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 26: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 28: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 29: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 30: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034

List of Figures

  • Figure 01: Global Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 02: Global Cell Therapy Market Share Analysis, by Type, 2023
  • Figure 03: Global Cell Therapy Market Share Analysis, by Type, 2034
  • Figure 04: Global Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 05: Global Cell Therapy Market Value (US$ Mn), by T-cell Therapy, 2020-2034
  • Figure 06: Global Cell Therapy Market Value Share Analysis, by T-cell Therapy, 2024 and 2034
  • Figure 07: Global Cell Therapy Market Value (US$ Mn), by Stem Cell Therapy, 2020-2034
  • Figure 08: Global Cell Therapy Market Value Share Analysis, by Stem Cell Therapy, 2024 and 2034
  • Figure 09: Global Cell Therapy Market Value (US$ Mn), by Natural Killer Cells, 2020-2034
  • Figure 10: Global Cell Therapy Market Value Share Analysis, by Natural Killer Cells, 2024 and 2034
  • Figure 11: Global Cell Therapy Market Value (US$ Mn), by Dendritic Cells, 2020-2034
  • Figure 12: Global Cell Therapy Market Value Share Analysis, by Dendritic Cells, 2024 and 2034
  • Figure 13: Global Cell Therapy Market Value (US$ Mn), by Other Cell Therapies, 2020-2034
  • Figure 14: Global Cell Therapy Market Value Share Analysis, by Other Cell Therapies, 2024 and 2034
  • Figure 15: Global Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 16: Global Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 17: Global Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 18: Global Cell Therapy Market Attractiveness Analysis, by Origin, 2024-2034
  • Figure 19: Global Cell Therapy Market Value (US$ Mn), by Autologous Therapies, 2020-2034
  • Figure 20: Global Cell Therapy Market Value Share Analysis, by Autologous Therapies, 2024 and 2034
  • Figure 21: Global Cell Therapy Market Value (US$ Mn), by Allogenic Therapies, 2020-2034
  • Figure 22: Global Cell Therapy Market Value Share Analysis, by Allogenic Therapies, 2024 and 2034
  • Figure 23: Global Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 24: Global Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 25: Global Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 26: Global Cell Therapy Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 27: Global Cell Therapy Market Value (US$ Mn), by Oncological Disorders, 2020-2034
  • Figure 28: Global Cell Therapy Market Value Share Analysis, by Oncological Disorders, 2024 and 2034
  • Figure 29: Global Cell Therapy Market Value (US$ Mn), by Autoimmune Disorders, 2020-2034
  • Figure 30: Global Cell Therapy Market Value Share Analysis, by Autoimmune Disorders, 2024 and 2034
  • Figure 31: Global Cell Therapy Market Value (US$ Mn), by Neurological Disorders, 2020-2034
  • Figure 32: Global Cell Therapy Market Value Share Analysis, by Neurological Disorders, 2024 and 2034
  • Figure 33: Global Cell Therapy Market Value (US$ Mn), by Others, 2020-2034
  • Figure 34: Global Cell Therapy Market Value Share Analysis, by Others, 2024 and 2034
  • Figure 35: Global Cell Therapy Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 36: Global Cell Therapy Market Share Analysis, by Region, 2023
  • Figure 37: Global Cell Therapy Market Share Analysis, by Region, 2034
  • Figure 38: Global Cell Therapy Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 39: North America Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 40: North America Cell Therapy Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 41: North America Cell Therapy Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 42: North America Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 43: North America Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 44: North America Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 45: North America Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 46: North America Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 47: North America Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 48: North America Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 49: North America Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 50: Europe Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 51: Europe Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 52: Europe Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 53: Europe Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 54: Europe Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 55: Europe Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 56: Europe Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 57: Europe Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 58: Europe Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 59: Europe Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 60: Europe Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 61: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 62: Asia Pacific Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 63: Asia Pacific Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 64: Asia Pacific Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 65: Asia Pacific Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 66: Asia Pacific Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 67: Asia Pacific Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 68: North America Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 69: Asia Pacific Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 70: Asia Pacific Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 71: Asia Pacific Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 72: Latin America Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 73: Latin America Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 74: Latin America Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 75: Latin America Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 76: Latin America Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 77: Latin America Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 78: Latin America Cell Therapy Market Attractiveness Analysis, by Origin, 2024-2034
  • Figure 79: Latin America Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 80: Latin America Cell Therapy Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 81: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 82: Middle East & Africa Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 83: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 84: Middle East & Africa Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 85: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 86: Middle East & Africa Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 87: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Origin, 2024-2034
  • Figure 88: Middle East & Africa Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 89: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Therapeutic Area, 2024-2034